Cholesterol-conjugated stapled peptides inhibit Ebola and Marburg viruses in vitro and in vivo.
Amino Acid Sequence
Animals
Antiviral Agents
/ chemistry
Cell Line
Cholesterol
/ chemistry
Disease Models, Animal
Ebolavirus
/ drug effects
Hemorrhagic Fever, Ebola
/ virology
Marburg Virus Disease
/ virology
Marburgvirus
/ drug effects
Mice
Microbial Sensitivity Tests
Models, Molecular
Peptides
/ chemistry
Protein Conformation
Structure-Activity Relationship
Cholesterol
Ebola virus
Peptides
Rodents
Therapeutic
Journal
Antiviral research
ISSN: 1872-9096
Titre abrégé: Antiviral Res
Pays: Netherlands
ID NLM: 8109699
Informations de publication
Date de publication:
11 2019
11 2019
Historique:
received:
09
06
2019
revised:
22
08
2019
accepted:
25
08
2019
pubmed:
2
9
2019
medline:
9
7
2020
entrez:
2
9
2019
Statut:
ppublish
Résumé
Filoviridae currently includes five official and one proposed genera. Genus Ebolavirus includes five established and one proposed ebolavirus species for Bombali virus (BOMV), Bundibugyo virus (BDBV), Ebola virus (EBOV), Reston virus (RESTV), Sudan virus (SUDV) and Taï Forest virus (TAFV), and genus Marburgvirus includes a single species for Marburg virus (MARV) and Ravn virus (RAVV). Ebola virus (EBOV) has emerged as a significant public health concern since the 2013-2016 Ebola Virus Disease outbreak in Western Africa. Currently, there are no therapeutics approved and the need for Ebola-specific therapeutics remains a gap. In search for anti-Ebola therapies we tested the idea of using inhibitory properties of peptides corresponding to the C-terminal heptad-repeat (HR2) domains of class I fusion proteins against EBOV infection. The fusion protein GP
Identifiants
pubmed: 31473342
pii: S0166-3542(19)30299-2
doi: 10.1016/j.antiviral.2019.104592
pii:
doi:
Substances chimiques
Antiviral Agents
0
Peptides
0
Cholesterol
97C5T2UQ7J
Types de publication
Journal Article
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
104592Informations de copyright
Published by Elsevier B.V.